Pharmarise Holdings Corporation

¥503.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:2796Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR 1.48%
Div yield 2.78%
ROE —
Medical (Pharmaceuticals)
Beta (5Y) 0.24
PE TTM 62.21
TSR TTM (1.61%)
Mkt cap ¥5.790B
ROIC 0.73%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥589
17.04%
5.83%
Hold 10|6|7|11|8
2Q26
3Q26
4Q26
1Q27
Earnings per share¥
6.23
6.23
6.50
6.50
22.89%
10.24%
12.62%
3.80%
Revenue¥M
418.9
411.0
422.8
431.3
(4.96%)
(4.30%)
(3.55%)
1.26%
Peers (US$36.76M)
Cap (US$)
PE
67.70M
—
19.91M
17.69x
45.63M
35.27x
Capital
TTM
5Y
10Y
Leveragex
3.963
4.155
3.035
EBIT/Intx
3.181
6.200
5.007
Own earn%
103.35
(154.13)
(122.21)
Sh yield%
42.97
53.79
51.22
Owners
Insiders/Inst%
8.09
86.99
Short interest%
3.20
SBC / revenue%
2.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
19–25
$1 testx
0.0
Incr. ROIC%
8